Evidence map›Paper›PMID 34880275›Full record

ArticleScientific reports2021

Novel cancer subtyping method based on patient-specific gene regulatory network.

Mai Adachi Nakazawa, Yoshinori Tamada, Yoshihisa Tanaka, Marie Ikeguchi, Kako Higashihara, Yasushi Okuno

Abstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Phenomics and Robust Multiomics Data for Cardiovascular Disease Subtyping.Arteriosclerosis, thrombosis, and vascular biology · 2023
    Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mai Adachi NakazawaGraduate School of Medicine, Kyoto University, Kyoto, 606-8507, Japan.
Yoshinori TamadaGraduate School of Medicine, Kyoto University, Kyoto, 606-8507, Japan. y.tamada@hirosaki-u.ac.jp.
Yoshihisa TanakaGraduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, 606-8507, Japan.
Marie IkeguchiGraduate School of Medicine, Kyoto University, Kyoto, 606-8507, Japan.
Kako HigashiharaGraduate School of Medicine, Kyoto University, Kyoto, 606-8507, Japan.
Yasushi OkunoGraduate School of Medicine, Kyoto University, Kyoto, 606-8507, Japan. okuno.yasushi.4c@kyoto-u.ac.jp.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The identification of cancer subtypes is important for the understanding of tumor heterogeneity. In recent years, numerous computational methods have been proposed for this problem based on the multi-omics data of patients. It is widely accepted that different cancer subtypes are induced by different molecular regulatory networks. However, only a few incorporate the differences between their molecular systems into the identification processes. In this study, we present a novel method to identify cancer subtypes based on patient-specific molecular systems. Our method realizes this by quantifying patient-specific gene networks, which are estimated from their transcriptome data, and by clustering their quantified networks. Comprehensive analyses of The Cancer Genome Atlas (TCGA) datasets applied to our method confirmed that they were able to identify more clinically meaningful cancer subtypes than the existing subtypes and found that the identified subtypes comprised different molecular features. Our findings also show that the proposed method can identify the novel cancer subtypes even with single omics data, which cannot otherwise be captured by existing methods using multi-omics data.

Indexed as

Gene Regulatory NetworksCluster AnalysisDatasets as TopicFemaleHumansKaplan-Meier EstimateMaleNeoplasmsSequence Analysis, RNATranscriptome

Identifiers

PMID34880275
PMCPMC8654869

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.